engleski

Comparison of current and preferred status of HTA implementation in central and eastern europen countries

Objectives To assess current status of HTA implementation in Central- Eastern European (CEE) countries and to identify long-term objectives considering country specific aspects and regional commonalities. Methods An HTA implementation survey was designed to identify, present and discuss HTA roadmaps in CEE countries. The survey was conducted among participants at the Fifth Adriatic Congress of Pharmacoeconomics and Outcomes Research (Sibenik) and at the Pilot ISPOR HTA Training for CEE countries in June 2015 (Zagreb). Opinion of respondents on current and preferred future status of HTA implementation in their own country were described related to capacity building, HTA financing, process and organisational structure for HTA, standardization of HTA methodology, use of local data, scope of mandatory HTA, and decision criteria. Results 41 participants (78% public sector employees) from 11 CEE countries filled in the survey. 75% of respondents would prefer postgraduate training for HTA capacity building, however, only 15% reported a currently implemented program and 33% reported no regular HTA trainings in their countries. Participants would increase public funding on HTA research (6% current vs. 65% preferred) and on critical appraisal of HTA submissions (15% current vs. 64% preferred). 73% of participants would prefer establishment of public HTA agency with academic support, however only 10% reported the existence of such agency. 92% of respondents would mandate the use of local data with need for assessing the transferability of international evidence (vs. 34% currently). 86% would prefer development of patient registries and access to data in payers’ databases (vs. 11% currently). Conclusions Our results must be viewed as an initial step in a multi- stakeholder dialogue on HTA implementation. Each CEE country should develop their own HTA roadmap, as such roadmaps are not fully transferable without taking into account country size, GDP per capita, major social values, public health priorities and fragmentation of health care financing.

Health Technology Assessment ; Central-Eastern European (CEE) countries ; Local data

nije evidentirano